“…Female gender, comorbid epilepsy, and the presence and degree of ID have been associated with higher mortality rates in those on the autism spectrum (Gillberg, Billstedt, Sundh, & Gillberg, ; Hirvikoski et al, ; Mouridsen, Bronnum‐Hansen, Rich, & Isager, ; Shavelle, Strauss, & Pickett, ). Studies also suggest that mortality for those on the spectrum is associated with concurrent ID and its related medical comorbidities, such as cardiovascular disease and other mental/behavioral disorders, rather than an outcome of autism spectrum disorder (ASD) itself (Bilder et al, ; Mouridsen, ; Schendel et al, ). Alternatively, co‐occurrence between ASD and other factors such as social or financial disadvantage (Henninger & Taylor, ; Howlin, ), poor access to or insufficient health services (Nicolaidis et al, ), inadequate or under‐skilled health workforce (Zerbo, Massolo, Qian, & Croen, ), and polypharmacy (Lake, Balogh, & Lunsky, ) may contribute to excess mortality.…”